arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 7/2011 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Cannabinoid SATIVEX for spasticity due to multiple sclerosis

    Apixaban (ELIQUIS) for prevention of thromboembolism

    Me-too statin pitavastatin (LIVAZO)

    THERAPY FROM A CRITICAL VIEWPOINT

    No benefit: study with extended-release nicotinic acid (NIASPAN) stopped

    a-t READER'S QUESTIONS AND COMMENTS

    Concerning the off-label use of bevacizumab for macular degeneration

    IN BRIEF

    FOLFIRINOX for pancreatic cancer

    Breast implants are not lifetime devices

    Misleading sun protection factors

    CURRENT ADR NETWORK REPORT

    Liver damage with UMCKALOABO
    free

    SIDE EFFECTS

    Cave: myopathy due to simvastatin (ZOCOR, generics) 80 mg daily

    End of glitazone antidiabetic pioglitazone (e.g. ACTOS)

    Angiotensin II receptor antagonists: FDA finds no increased risk of cancer

    e a-t IN THE INTERNET

    What is the benefit of the meningococcal vaccine MENVEO?

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles